文献速递鼻科

所有慢性鼻窦炎内型聚类在鼻内镜手术后均显示患者报告和临床结局指标改善

All chronic rhinosinusitis endotype clusters demonstrate improvement in patient-reported and clinical outcome measures after endoscopic sinus surgery.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-08-25

前瞻性多中心观察性研究纳入115例慢性鼻窦炎患者,术前采集嗅裂黏液检测26种生物标志物并进行聚类分析。基于蛋白水平分为2型炎症、非2型炎症、非炎症及两个不确定聚类。所有内型聚类在鼻内镜术后6个月的患者报告和临床结局指标均改善,组间无统计学显著差异。

要点

  • 基于术前嗅裂黏液26种生物标志物可将慢性鼻窦炎分为5个内型聚类。
  • 所有内型聚类在鼻内镜术后SNOT-22、QOD、TDI和LKES均改善。
  • 各内型聚类间术后结局指标改善无统计学显著差异。

核心结论

  • 所有慢性鼻窦炎内型聚类对手术反应良好,患者报告和客观结局指标均改善。
  • 鼻内镜手术应被视为更通用的慢性鼻窦炎治疗,获益似乎不限于特定内型。

研究设计与样本

  • 前瞻性多中心观察性研究,2016年至2021年招募慢性鼻窦炎患者,共115例纳入聚类分析。
  • 术前采集嗅裂黏液,使用聚类分析评估26种生物标志物。
  • 患者报告结局包括22项鼻窦结局测试(SNOT-22)和嗅觉功能障碍问卷(QOD)。
  • 临床疾病严重程度指标包括Sniffin' Sticks测试的阈值、辨别和识别(TDI)评分及Lund-Kennedy内镜评分(LKES)。

主要发现

  • 基于个体蛋白水平,115例患者被聚类为2型炎症、非2型炎症、非炎症和两个不确定聚类。
  • 2型炎症聚类在鼻内镜术后6个月SNOT-22平均改善-28.3(标准差±16.2),TDI平均改善6.5(标准差±7.9),为各聚类中最高。
  • 所有内型聚类在鼻内镜术后平均所有结局指标均改善,组间SNOT-22(p=0.738)、QOD(p=0.306)、TDI(p=0.358)和LKES(p=0.514)无统计学显著差异。

临床怎么用

  • 作者认为鼻内镜手术应被视为更通用的慢性鼻窦炎治疗,获益似乎不限于特定内型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unclear whether chronic rhinosinusitis (CRS) endotypes show a differential response to endoscopic sinus surgery (ESS). We explored patient mucous inflammatory cytokine expression and associations with patient-reported and clinically measured post-operative outcome measures. METHODS: Patients with CRS were prospectively recruited between 2016 and 2021 into a national multicenter, observational study. Mucus was collected from the olfactory cleft preoperatively and evaluated for 26 biomarkers using cluster analysis. Patient-reported outcome measures included the 22-item Sino-Nasal Outcome Test (SNOT-22) and Questionnaire of Olfactory Dysfunction (QOD). Additional clinical measures of disease severity included threshold, discrimination, and identification (TDI) scores using "Sniffin' Sticks" testing and Lund-Kennedy endoscopic score (LKES). RESULTS: A total of 115 patients were clustered into type 2 inflammatory, non-type 2 inflammatory, noninflammatory, and two indeterminate clusters based on individual protein levels. Overall, the type 2 inflammatory cluster was found to have the highest mean improvement in both SNOT-22 (-28.3 [standard deviation, ±16.2]) and TDI (6.5 [standard deviation, ±7.9]) scores 6 months after ESS. However, on average, all endotype clusters demonstrated improvement in all outcome measures after ESS without statistically significant between-group differences in SNOT-22 (p = 0.738), QOD (p = 0.306), TDI (p = 0.358), or LKES (p = 0.514) measures. CONCLUSIONS: All CRS endotype clusters responded favorably to surgery and showed improvements in patient-reported and objective outcome measures. Thus, ESS should be considered a more generalized CRS therapy, and benefits appear to not be limited to specific endotypes.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Chapurin N, Schlosser RJ, Gutierrez J, et al. All chronic rhinosinusitis endotype clusters demonstrate improvement in patient-reported and clinical outcome measures after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2023. PMID: 37563836. doi:10.1002/alr.23255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。